For research use only
| Cat No. | ABC-X0337C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human KIF5B_RET (L730Q) BAF3 Cell Line enables functional analysis of RET fusions in tumorigenic transformation and RET-targeted drug screening.
Human KIF5B_RET (L730Q) BAF3 Overexpression Cell Line is a lentivirally modified Ba/F3 model expressing the oncogenic KIF5B_RET fusion containing the L730Q mutation. The cells are validated by qRT-PCR and cultured below passage 20.
Target
The KIF5B_RET fusion leads to constitutive RET kinase activity, while the L730Q mutation is linked to enhanced oncogenic signaling and potential resistance to RET inhibitors. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0337C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This cell line serves as a preclinical model for dissecting RET-driven oncogenesis and for screening RET-targeted therapies, particularly against resistant mutations.